Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?

SC immunotherapy reduces chair time from 5-7 hours to 7 minutes but faces 45% reimbursement reduction and higher drug dose requirements.

Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency? Read More ยป